the cells of the nasal mucosa might respond in a similar manner when flushed with antiviral serum.
EXPERTM~NTAL
The virus of pseudorabies (Aujeszky's disease, infectious bulbar paralysis, mad itch) was selected for most of the experiments because its properties rendered it particularly suitable for this type of investigation. It produces a rapidly fatal (2 to 4 days) encephalitis in guinea pigs, following a single nasal instillation of minute amounts of virus. This virus invades the blood stream and viscera as well as the central nervous system and, as shown by Hurst (7a, 7b) , in rabbits it reaches the central nervous system by way of the peripheral nerves. As a result of its almost constant and rapid destructive effect on the sensory ganglion cells which are first attacked, the sites, which the infected animals scratch or bite, serve to indicate the nerves along which the virus, in all probability, reached the central nervous system from the periphery (7a). Guinea pigs infected intranasally scratch along the nose, the eyes, the ears, or the jaw. This "marking or indicating" property of the virus appeared particularly useful for these experiments, since it would tend to show whether in treated animals encephalitis was induced by way of the nerves from the nose, or whether the virt~s had gotten through the possibly protected region of the nose into the blood stream and reached the central nervous system by way of the nerves supplying the viscera.
It has already been shown that while pseudorabies antiviral serum mixed with virus in vitro has no protective effect even against minimal doses when injected intracerebrally in guinea pigs, it does prevent infection when administered by the nasal route (6) . It remained to be determined, therefore, whether immune serum instilled in the nose prior to the administration of virus by this route would exert a protective effect.
The pseudorabies virus (Aujeszky strain) was always used in the form of fresh or glycerolated rabbit brain, obtained after intracerebral injection of the virus. Swine antipseudorabies serum 1 was used in most of the experiments. In preliminary tests 0.25 cc. of antiviral serum or of normal swine serum was dropped into each nostril, and an hour or two later, 0.25 cc. of a 10 per cent 1 Kindly supplied by Dr. R. E. Shope. centrifuged suspension of rabbit brain virus was instilled in each nostril. All of the guinea pigs treated with normal swine serum died, while an occasional one of those treated with immune serum survived. It appeared, however, that better results might perhaps be obtained by increasing the amount of immune serum to be instilled and diminishing the volume of the infective dose to a minimum in order to prevent it from getting into the lungs and to approximate natural conditions of infection by this route. The serum was increased to 0.5 cc. per nostril, administered slowly from a blunt, smooth edged, glass pipette, and the virus was reduced to 0.05 cc. for each nostril--an amount still larger than that ordinarily transmitted by natural droplet infection. A dose of 0.05 cc. per nostril of a 0.1 per cent virus suspension killed about half the number of control guinea pigs, while with the same amount of a 1 or 2 per cent suspension, only an occasional one survived. In view of variations encountered with different virus preparations, each experiment necessarily had its own controls, and 1 per cent virus suspension was used when made with fresh brain and 2 per cent or 5 per cent with glycerolated tissue.
Effect of Intranasal and Intramuscular Administration of Antipseudorabies Serum.--The purpose of this experiment was (a) to
determine whether the nasal instillation of i m m u n e serum would protect against a small, yet ordinarily fatal, a m o u n t of pseudorabies virus introduced in the nose 2 hours later; (b) to determine whether an i m m u n e serum homologous for the test animal, i,e., guinea pig in this case, might be more effective than the heterologous swine serum, and (c) to determine, in p a r t at least, whether the effect of the nasally instilled serum is local, or remote after absorption, b y comparing it with t h a t produced b y the intramuscular injection of an even larger a m o u n t of immune serum.
Sixteen guinea pigs were divided into four groups. One was untreated; the animals of the second group each received 3 cc. of swine antipseudorabies serum intramuscularly, while those of the third group were given 0.5 cc. of the same serum in each nostril; the guinea pigs of the fourth group received 0.5 cc. in each nostril of guinea pig antipseudorabies serum.* 2 hours later all animals were instilled in each nostril with 0.05 cc. of a 2 per cent virus suspension.
T h e results are shown in TaMe I. All the guinea pigs which received the i m m u n e serum intranasally survived without showing a n y signs of disease, while all those which were given the serum intramuscularly and three of the four untreated ones died with typical 2 Prepared and kindly supplied by Dr. R. E. Shope.
signs of pseudorabies on the 3rd day after inoculation. This :experiment indicates that (a) immune serum, either homologous or heterologous as regards the host, instilled into the nose, is capable of protecting the host for a period of at least 2 hours against invasion with :~ D3 = died on 3rd day after inoculation, with evidence of scratching some part of the head. pseudorabies b y way of the nose, and (b) in view of the fact t h a t the intramuscular injection of an even larger a m o u n t of immune serum (about 1 cc. per 100 gm.) failed to prevent infection, the action of the nasally instilled serum was necessarily a local one. T h e possibility of greater absorption of a diffusible agent into the cerebrospinal fluid from the nose than from muscle is not significant, because immune serum, even when mixed with pseudorabies virus in vitro, appears to be incapable of preventing infection when the mixture is injected intracerebrally in guinea pigs (6) . In view of the fact that pseudorabies can spread in the body by routes other than the neural, it is interesting to observe that protection of the "first line" of cells to be attacked apparently also acts as a barrier to the further dissemination of the virus to other parts of the body where the cells are fully susceptible.
It may be said by some that the virus is "neutralized" by the immune serum, which obviously must remain adherent to the nasal mucosa, and for that reason is inactive wherever it may spread. But previous experiments on the mechanism of the neutralizing or protective action of antipseudorabies serum (5, 8) which showed no evidence of union between the virus and the protective antibody during the consummation of the immune process, make it difficult to accept this explanation. The experiments just referred to (5) also indicated that susceptible cells rendered refractory in the presence of immune serum are capable of fixing virus apparently to the same extent as normal cells, but that the virus fixed to such refractory cells fails to multiply and becomes inactive at a rate which varies with different viruses at body temperature under conditions unfavorable to multiplication. On this basis, one can imagine how a superficial layer of protected cells may act as a barrier to deeper dissemination of the virus, provided the dose is not too large, without resorting to a concept of direct "neutralization."
Duration of Protective Action of Immune Serum in the Nose and Effect of Certain Chemical Substances.--
To determine the duration of the protective effect of nasally instilled immune serum, three groups of four guinea pigs were treated with 0.5 cc. of swine antipseudorabies serum in each nostril. One group received the serum 24 hours before, another 5 hours before, and the third, 2 hours before the time when they were all given 0.05 cc. of a 2 per cent virus suspension in each nostril. Four guinea pigs were treated with 1 per cent tannic acid (0.5 co. in each nostril) to determine the effect of a single treatment with an astringent, protein-precipitating substance (9) . 0.1 per cent neutral acriflavine was used in a similar manner in another four guinea pigs; this chemical has been reported by Craigie and Tulloch (10) as capable of rendering the rabbit skin refractory to infection with vaccinia virus. The neutral acriflavine by itself was shown by them not to be virucidal, as evidenced by the fact that upon dilution of such an inactive mixture to a point at which the concentration of acriflavine became too dilute to be effective, they obtained a suspension which was again infective. The eight chemically treated guinea pigs and three untreated ones received pseudorabies virus intranasally along with the serum-treated animals.
The results (Table II) confirm the observations of the previous experiment, in that all the guinea pigs receiving virus 2 hours after the serum survived without showing any signs of disease, and demonstrate further that definite protection is evident at 5 hours, while an occasional guinea pig may perhaps still be resistant at 24 hours. All the animals which were treated either with 1 per cent tannic acid or the 0.1 per cent neutral acriflavine died with typical signs of pseudorabies, as did two of the three untreated ones.
There are several points in this experiment which may be stressed. One, the relatively short duration of the protective action of nasally instilled immune serum, may be accounted for by the probable washing out effect of the nasal secretions, which is in agreement with observations showing that in vitro minced, susceptible tissue, rendered refractory to infection by exposure to antiviral serum, may again become susceptible after repeated washing (5) . It has also been recorded (11) that the testes from a rabbit actively immune to Virus III may, by washing, be rendered susceptible to infection in vitro.
The negative results with neutral acriflavine are of interest since it may mean that its action in the nose differs from that in the skin, or that its protective effect may be limited only to certain viruses, both possibilities being worthy of further study.
Influence of Quantity of Serum Administered.--When 0.5 cc. of serum is instilled into each nostril of a guinea pig, possibly the greater portion of it is lost by sneezing or swallowing. Yet, when half that amount of immune serum, i.e., 0.25 co., was used in the preliminary experiments and the dose of virus was equally large, protection rarely followed. In view of the results of the preceding experiments, it appeared possible that this difficulty was due mainly to the larger volume or amount of virus which either spread more easily beyond protected zones or persisted after the effect of the serum had worn off. In the present test the effectiveness of the 0.25 and 0.5 cc. doses was compared in two groups of four guinea pigs (Table III) . The dose of virus, which was 0.05 co. of a 5 per cent suspension for each nostril, proved less infective than anticipated, since only two of the four controls developed the disease and died. It is noteworthy, however, that none of the serum-treated guinea pigs, which received this dose of virus 4 hours after the serum, showed any signs of disease.
Attempts at Prolonging the Duration of the Protective Effect of Nasally
Instilled Immune Serum.--Since the relatively rapid loss of the refractory state induced by the nasal instillation of immune serum may b e a t t r i b u t a b l e to t h e fact t h a t it is w a s h e d a w a y b y t h e n a s a l secretions, several a t t e m p t s were m a d e to d e t e r m i n e w h e t h e r c e r t a i n a g e n t s m a y h e l p to r e t a i n t h e s e r u m in the nose for a l o n g e r time.
In the first experiment, three parts of immune serum were mixed with one part respectively of saline, glycerol, or liquid paraffin, each mixture (0.5 cc. for each nostril) was given to a group of four guinea pigs, and the virus was administered 2 hours after treatment. The results, shown in Table IV , indicate that while glycerol and liquid paraffin did not inhibit the action of the serum, they exerted no appreciable effect, since all the guinea pigs treated with the serum- saline mixture survived, while one of the four in each of the other two groups developed the disease and died. Eight guinea pigs were treated with immune serum mixed with sufficient agar (about 0.66 per cent) to make a gelatinous mass and tested with virus 6 and 24 hours later, but they behaved as did the controls, all succumbing in average time. Dried serum mixed with petrolatum was totally ineffective. Eight guinea pigs were treated with immune serum in the usual manner and within 20 to 30 minutes each was given 0.25 cc. of 0.66 per cent tannic acid per nostril to determine the possible effect of precipitating the serum in situ. Virus was given 6 and 24 hours later. No advantage over the ordinary serum-treated guinea pigs was secured (Table V) .
Tests for Active Immunity in Protected Guinea
Pigs.--Twelve guinea pigs which, as a result of the nasal instillation of immune serum, proved to be refractory to a generally lethal test dose of pseudorabies virus, were retested with the same dose and by the same route 10 to 15 days later to determine whether or not they had acquired any 
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active immunity. As all of them developed typical pseudorabies and died, it could be assumed that the primary treatment had protected them completely from the effects of the virus so that no active immunity ensued. 9-0 9-1 9-2 9-3 9-4 9-5 9-5 9-7 9-8 9-9 1-00 w h e t h e r t h e p h e n o m e n o n of local i m m u n e s e r u m p r o t e c t i o n a g a i n s t i n f e c t i o n b y the n a s a l r o u t e occurred w i t h a n o t h e r v i r u s a n d in a no t h e r host. the test dose was only 0.02 cc. in order to prevent as far as possible its being aspirated into the lungs. One group of six mice received the virus 2 hours after treatment and the other group after an interval of 4 hours. The infectivity of the virus suspension by the nasal route was simultaneously titrated on mice of similar age. As shown in Table VI , while all the control mice which received 0.02 cc. of the 1:200, l:l,000, and 1:10,000 dilutions of the virus, and one of three of the 1 : 100,000 group developed a fatal encephalitis, none of the six mice treated 2 hours before receiving virus showed any signs of disease and only two of the six mice treated 4 hours before infection developed encephalitis. The ten protected, surviving mice were tested for active immunity 18 days later and all succumbed, indicating, as in the case of pseudorabies, the lack of an active immunity.
Experiments with Mice and Equine Encephalomyelitis Virus (Eastern Strain).--The purpose of the following experiments was to determine
A suspension of the virus in broth has been found to be considerably more encephalitogenic in mice than one in saline, and when 0.03 cc. instead of 0.02 cc. of virus suspension in broth was used as the nasal test dose, protection rarely occurred (Experiment II, Table VI, and others). With saline suspensions of virus, protection was shown with both doses. It should also be stated that while in the case of pseudorabies the intramuscular injection of 3 cc. of immune serum to guinea pigs weighing about 300 gin., or the equivalent of l0 cc. per kilo, failed to protect them against nasal infection with a dose in the minimal effective range, four 20 gin. mice, each receiving 1 cc. of immune serum intraperitoneally, or the equivalent of 50 cc. per kilo, 4 hours before infection, were protected against a lethal amount of equine encephalomyelitis virus given by the nasal route. F r o m these experiments it appears t h a t while passive systemic immunity against nasal infection, that is, against invasion of virus by the nasal route, is not an impossibility, it is nevertheless difficult to achieve probably because of the relatively large amount of antibody required in larger hosts.
DISCUSSION
The purpose of this communication is to present evidence that the nasal mucosa and the nerve endings in it m a y be protected temporarily from infection with certain viruses by a preliminary flushing or spraying of these tissues with immune serum, and that when these primary receptor cells for the virus are so blocked or protected, the virus does not invade the rest of the organism and disease does not ensue. T h a t the action of the immune serum thus introduced in the nose is a local one is apparent from an experiment in which larger amounts of the same serum given systemically failed, in the case of pseudorabies virus, to protect guinea pigs against infection by the nasal route. If, as is generally assumed, the virus comes in direct contact with nervous elements in the nose, the phenomenon of specific local protection in this region is particularly noteworthy in the case of pseudorabies in the guinea pig, since the immune serum is practically devoid of any antiviral action when introduced with the virus directly into the brain, and it would appear, therefore, that in this instance, at least, the capacity or mode of protection may be different in peripheral and central nervous tissues. The subject is obviously one calling for further study.
The protective effect of immune serum in the nose begins immediately after instillation, is still evident 5 hours later, and usually is entirely dissipated by the end of 24 hours. Attempts to prolong its effect by incorporating with the serum substances such as glycerol, liquid paraffin, semisolid agar, petrolatum, and by precipitating the serum in situ with tannic acid proved unsuccessful.
S U M M A R Y
i. Immune serum instilled intranasally in guinea pigs has protected them from infection with lethal amounts of pseudorabies virus by the nasal route. The same effect was obtained in mice with immune serum against the virus of equine encephalomyelitis (Eastern strain).
2. The protective effect of the immune serum in the nose begins at the time of instillation, is still evident 5 hours later, and usually has disappeared by the end of 24 hours.
3. Attempts to prolong the local effectiveness of immune serum by means of several devices were unsuccessful.
4. The action of the immune serum appears to be a local one in the nose, in view of the fact that the administration of even larger amounts of it intramuscularly failed to protect guinea pigs against infection with pseudorabies by the nasal route.
